
    
      A prospective, multicenter, single-arm trial evaluating the safety and efficacy of the
      Jetstream Atherectomy System in the treatment of symptomatic occlusive atherosclerotic
      lesions â‰¤150 mm in length located in the femoropopliteal arteries in subjects with symptoms
      classified as Rutherford categories 2-4.
    
  